Long-term dual antiplatelet therapy and concomitant optimal medical therapy following percutaneous coronary intervention

被引:1
|
作者
Gargiulo, Giuseppe [1 ,2 ]
Valgimigli, Marco [1 ]
机构
[1] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland
[2] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
关键词
ELUTING STENT IMPLANTATION; PRE-SPECIFIED ANALYSIS; CLINICAL-OUTCOMES; BLEEDING OUTCOMES; OPTIMAL DURATION; BARE-METAL; IMPACT; METAANALYSIS; INSIGHTS; SEX;
D O I
10.21037/cdt.2017.03.10
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S102 / S106
页数:5
相关论文
共 50 条
  • [1] Long-term dual antiplatelet therapy after percutaneous coronary intervention
    Messori, Andrea
    Fadda, Valeria
    Trippoli, Sabrina
    [J]. HEART, 2010, 96 (18) : 1512 - 1512
  • [2] Smoking influences the effectiveness of dual antiplatelet therapy on long-term outcomes following percutaneous coronary intervention
    Kiran, YA
    Steinhubl, SR
    Hsu, AP
    Topol, EJ
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 36B - 36B
  • [3] Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy
    DeEugenio, Deborah
    Kolman, Louis
    DeCaro, Matthew
    Andrel, Jocelyn
    Chervoneva, Inna
    Duong, Phu
    Lam, Linh
    McGowan, Christopher
    Lee, Grace
    DeCaro, Mark
    Ruggiero, Nicholas
    Singhal, Shalabh
    Greenspon, Arnold
    [J]. PHARMACOTHERAPY, 2007, 27 (05): : 691 - 696
  • [4] Optimal Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: An Umbrella Review
    Elliott, Jesse
    Kelly, Shannon E.
    Bai, Zemin
    Liu, Wenfei
    Skidmore, Becky
    Boucher, Michel
    So, Derek Y. F.
    Wells, George A.
    [J]. CANADIAN JOURNAL OF CARDIOLOGY, 2019, 35 (08) : 1039 - 1046
  • [5] Long-term Impact of Baseline Anemia and Dual Antiplatelet Therapy Duration After Percutaneous Coronary Intervention
    Kim, Huntae
    Park, Jong-Il
    Kim, Byung-Jun
    Lee, Jung-Hee
    Kim, Ung
    Park, Jong-Seon
    [J]. CIRCULATION, 2020, 142
  • [6] Dual Antiplatelet Therapy Cessation due to Bleeding Complication is Related to Long-Term Clinical Outcome Following Percutaneous Coronary Intervention
    Tanaka, Shigemitsu
    Ikari, Yuji
    Komai, Taichi
    Ijichi, Takeshi
    Yanagiswa, Katsuaki
    Kamiyama, Yoshinari
    Nakazawa, Gaku
    Masuda, Naoki
    Matsukage, Takashi
    Ogata, Nobuhiko
    Morino, Yoshihiro
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 56 (13) : B26 - B27
  • [7] Optimal duration of dual antiplatelet therapy following percutaneous coronary intervention: protocol for an umbrella review
    Elliott, Jesse
    Kelly, Shannon E.
    Bai, Zemin
    Liu, Wenfei
    Skidmore, Becky
    Boucher, Michel
    So, Derek Y. F.
    Wells, George A.
    [J]. BMJ OPEN, 2017, 7 (04):
  • [8] Long-term care after percutaneous coronary intervention: Focus on the role of antiplatelet therapy
    Stone, GW
    Aronow, HD
    [J]. MAYO CLINIC PROCEEDINGS, 2006, 81 (05) : 641 - 652
  • [9] What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?
    Steinhubl, S
    Berger, P
    [J]. AMERICAN HEART JOURNAL, 2003, 145 (06) : 971 - 978
  • [10] Update on dual antiplatelet therapy for percutaneous coronary intervention
    Prasad, Abhiram
    Holmes, David R.
    [J]. HEART, 2009, 95 (11) : 861 - 865